跳至主要内容
临床试验/CTRI/2014/06/004646
CTRI/2014/06/004646进行中(未招募)2 期

An open pilot clinical study on Aan maladu [Male Infertility]with the evaluation of trial drug Nerunjil vithai chooranam.

未提供1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2013年10月5日最近更新:
适应症

试验速览

阶段
2 期
状态
进行中(未招募)
入组人数
20
试验地点
1
主要终点
Semen Analysis is done before and after treatment.

研究概览

简要总结

Nerunjil vithai chooranam is a polyherbal formulation, main ingredients are asparagus resemosus,mucuna pruriens,tribulus terrestris. In literature all ingredients of NVC have  aphrodisiac action. NVC is a safest and most effective for male infertility. 20 patients included in the trial and trial drug is given and monitered.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
21.00 Year(s) 至 45.00 Year(s)(—)
性别
Male

入选标准

  • •Oligospermia, Oligoasthenospermia, Willing to give semen for investigation.

排除标准

  • •Diabetes mellitus , Hypertension, Cardiac diseases, Hydrocele, Azoospermia, Vericocele.

结局指标

主要结局

Semen Analysis is done before and after treatment.

时间窗: After 48 days of treatment semen analysis is repeated.

次要结局

  • LFT and RFT is measured before and after treatment.(After 48 days of treatment saftey parameters are repeated.)

研究者

发起方
未提供

研究点 (1)

Loading locations...

相似试验